Cardiovascular disease (CVD) is one of the leading causes of death worldwide. In the past decade CVD has been the cause of over one-third of all premature deaths in Australia. LDL particles are heterogeneous with varying density, size, charge and composition. Small dense LDL particles are especially atherogenic and have been linked to an increased risk for coronary artery disease (CAD). These particles penetrate the arterial wall more easily and readily bind with intimal proteoglycans, which may further increase the susceptibility of the lipoprotein to oxidation.
The NutriPATH Oxidised LDL test is an advanced biomarker for coronary artery disease. This test measures levels of oxidised low density lipoproteins using a highly sensitive and specific analyses. This test is Low density lipoproteins (LDL), the major carrier of circulating cholesterol, are very susceptible to oxidation. It is seen that elevated oxidised LDL is associated with accelerated atherogenesis, CAD, acute myocardial infarction, stable and unstable angina and metabolic syndrome. This assessment can either be orders as an individual marker or as a combination with LDL subfractions test code 4031.
- Coronary Artery Disease
- Heart Attack
- Metabolic Syndrome
- Type 2 Diabetes
- Oxidative Stress
- Family history of heart disease
- High Cholesterol